Page last updated: 2024-09-04

moxifloxacin and Colonic Neoplasms

moxifloxacin has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fabian, I; Halperin, D; Priel, E; Reuveni, D; Shalit, I	1

Other Studies

1 other study(ies) available for moxifloxacin and Colonic Neoplasms

Article	Year
Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line. International journal of oncology, 2010, Volume: 37, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Aza Compounds; Carcinoma; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Cytotoxins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Inhibitors; Etoposide; Fluoroquinolones; HT29 Cells; Humans; Moxifloxacin; Quinolines; Topoisomerase II Inhibitors	2010

Article

Year

Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line.

International journal of oncology, 2010, Volume: 37, Issue:2

Topics: Antineoplastic Agents; Apoptosis; Aza Compounds; Carcinoma; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Cytotoxins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Inhibitors; Etoposide; Fluoroquinolones; HT29 Cells; Humans; Moxifloxacin; Quinolines; Topoisomerase II Inhibitors

2010